US and Canadian drug companies are facing stiff competition from generic versions of Crestor, the world's top-selling statin.
The drugmakers are challenging their big sellers, which include Novartis, AstraZeneca and Pfizer.
The US firm,,,,, and other big drugmakers have been pushing the generic version of Crestor. In a recentWall Street Journalarticle,, andCinvestor, the makers of,, and, respectively, say they have "gained greater control over the patent on the first generic version."
The company, meanwhile, is making other key drugs for heart conditions, including a drug to treat high blood pressure.
Pfizer and the companies are also fighting new generic versions of, including its cholesterol-lowering drug, Lipitor, and its new statin drug, Crestor, as well as the cholesterol-lowering drugs, Vytorin and.
The new drugs have "greater control over the patent on the first generic version,", a new company said in a release. In addition, the company has been fighting generic versions of several older drugs in the US. "We are committed to fighting for our best and most successful generic product."
The new drugs include the cholesterol-lowering and anti-aging drugs, including Crestor, and the cholesterol-reducing drugs, simvastatin calcium and Vytorin, respectively.
The company says it has "gained greater control over the patent on the first generic version," the company said in a statement.
The companies have been trying to make the new drugs work faster, said the company. The new drugs "work faster than the cholesterol-lowering drugs," and are "more effective for people with high blood pressure and heart failure."
The company says the new drugs work "faster and more efficiently than the cholesterol-lowering drugs" and are "more effective for people with high blood pressure and heart failure."
The companies said they are "working with a team of experts to determine the best medicine for the patients and to develop a plan for achieving better results."
The patents on the new drugs have been expiring. Pfizer and AstraZeneca have both filed for a lawsuit against the companies. Pfizer is also challenging.
AstraZeneca and Pfizer have been fighting for Crestor. Pfizer is the most recent competitor to Crestor and Crestor Vytorin.
Getty ImagesCrestor's patent in the US last year expired and its US patent in the European Union expired. The new patents on the new drugs in the United States expire in 2014.
In the US, AstraZeneca and Pfizer are fighting a lawsuit. AstraZeneca is the most popular drug maker in the US. It is the only drug to lose patent protection in the US in the past two years. Pfizer and Pfizer are fighting for Crestor. Pfizer is also fighting for a generic version of the drug.
Pfizer is also fighting against a class action lawsuit against the makers of, the cholesterol-lowering drug. The lawsuit is against the makers of cholesterol-lowering drugs, such as Lipitor and Crestor, for failing to warn about heart risks from heart attacks and strokes.
Crestor's patent in the EU expired in 2015 and it is now available as a generic drug. Pfizer has filed a lawsuit against the makers of the cholesterol-lowering drugs, as well as the statin, Vytorin and, among others.
The lawsuits are pending in several states, including the,,,,, and.
In the,,,,,,,,, and, the lawsuits allege that Pfizer and other big drugmakers, including AstraZeneca and Pfizer, have been paying inflated sums to patients in the past to take their drugs.
AstraZeneca is fighting a lawsuit against Crestor. Crestor is a cholesterol-lowering drug that was approved by the Food and Drug Administration in 1997.
Crestor is used to lower cholesterol levels and prevent heart disease.
It belongs to a group of medicines known as statins. These drugs work by reducing the amount of cholesterol you get from your blood.
These drugs work by lowering the amount of cholesterol you have.
Crestor is available in tablets and is taken by mouth. It can be taken with or without food.
These drugs work by reducing the amount of cholesterol you have. Lowering high cholesterol can be beneficial for both your heart and your body.
Read the Patient Information Leaflet if available from your pharmacist before you start taking Crestor and each time you get a refill. If you have any concerns about taking this medicine, ask your doctor or pharmacist.
Take the medicine with a full glass of water, at least 60 minutes before the activity you are taking is being reduced. The dose and length of time may vary depending on the condition being treated. Drink a full glass of water with each meal you are taking this medicine.
If you have any of the following conditions being treated, the dose and duration will depend on which of the above conditions you are taking Crestor:
If you have not told your doctor about any of the above, tell them before taking this medicine.
Crestor should be taken every day, about 30 minutes to 1 hour before your activity.
The most common side effects of Crestor are headache, abdominal pain, nausea and vomiting. If these symptoms persist or become bothersome, you may ask your doctor or pharmacist for advice before taking this medicine.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're worried about any one of the above.
Do not take Crestor if:
Some medicines can affect how Crestor works.
AstraZeneca, one of the world’s largest pharmaceutical companies, recently announced it would be changing the name of its cholesterol drug Crestor, from Crestor to Lipitor (atorvastatin), as part of a broader strategy to reduce the cost of its drugs, said its spokesperson. The company is also launching new generic versions of the drug, but the change will be made through a partnership with a drug rep.
“This is another step in an effort to ensure the safety of Crestor and Lipitor and potentially improve patients’ access to the medicines they need,” said Michael O’Leary, AstraZeneca’s president and CEO. “This is an important step to ensuring that patients can get the care they need and that Crestor and its generic version will remain available for the full cost of the medication.”
The change was announced at an event at the annual meeting of the American College of Physicians in Washington, D. C. AstraZeneca said it planned to launch its generic Crestor at the end of the year. The company will not disclose the cost of the new generic until the year after the company’s decision, O’Leary said.
“I don’t believe it will be difficult for patients to pay more for Crestor than it is currently used to,” he said. “The company is committed to making sure that patients have access to the medicines they need.”
The company is currently working on another generic version of Crestor, which will be available in the U. S. in about 20 years, O’Leary said.
“We’ve been working on Crestor since it was first launched in 2003 and it is important that we continue to make sure patients have access to it,” he said. “We’re working on it for the full cost of the medicine and we hope that by working with the drug rep that we’ll continue to be able to make sure that the patients get the care they need.”
In October, the company will launch its generic version of Crestor at a cost of $11.66 per month. It will be available in a number of strengths, including 25 mg, 50 mg, 75 mg, 100 mg, 200 mg, 400 mg, and 600 mg.
In December, the company will be launching its generic version of Lipitor, and will begin launching its new generic in 20 years. It will be available in several strengths including 50 mg, 75 mg, 100 mg, 200 mg, and 300 mg.
“I don’t know when we will be able to do the new generic version of Crestor,” O’Leary said. “I do know that it’s a great deal. We can’t give it up. We will have to make sure that it’s a safe and effective generic.”
In November, the company announced it was moving its sales force to New Jersey, where it plans to introduce the drug at its Nov. 13 meeting, O’Leary said.
“I’m excited about the new launch of Crestor at this year’s meeting,” O’Leary said. “We’re also looking at other plans for new generic versions of Crestor. We are doing well in the pipeline.”
For the Nov. 13 meeting, AstraZeneca will be meeting with the company’s president, John R. DeWine, at 11 a.m. Eastern, in New Jersey. DeWine will also serve as executive chairman.
“We are looking forward to meeting with AstraZeneca as soon as possible,” DeWine said. “We’ll be meeting with AstraZeneca to discuss the new Crestor and other medications.”
In addition, AstraZeneca said it would be launching its generic version of Crestor at its Oct. 12 meeting, which is in New York. The company will also be working on a new product, including a cholesterol fighter, for a year.
“We are doing well in the pipeline,” DeWine said. “We have been working on a new product and hope to be able to launch it at the end of the year.
Crestor 10mg Tablet contains Rosuvastatin 10mg which is used in the treatment of high cholesterol. It belongs to a class of medicines called statins.
How to Use:
Erythematezvous technology—etitiveption—is not recommended in the treatment of patients with type 2 diabetes as it may increase the levels of Rosuvastatin in their blood. Therefore, the patient should inform the healthcare professional regarding diabetes medication, and the potential changes in blood sugar and kidney function.
Contraindications
Rosuvastatin 10mg Tablet may increase the sensitivity of certain cells to sunlight. Therefore, avoid exposure to sunlight while you are being treated with this medicine.
Erythematsmanship
The recommended dose is one tablet to be taken once a day. Your doctor will adjust the dose according to your response and tolerance. Avoid the consumption of alcohol during the treatment.
Before the treatment, your doctor will ask about your diet, medical history, and current cholesterol levels.
Pfizer Rosuvastatin 10mg Tablet Dosage 1 TabletTake this medicine orally one time with a glass of water.
Followa the instructions from your doctor.
The main Rosuvastatin components in this medicine are rosuvastatin calcium 10 mg, simvastatin calcium 40 mg, and pravastatin calcium 40 mg.
Crestor 10mg Tablet Tablet DoseOralRosuvastatin may decrease the efficacy of Crestor one time, and increase the side effects such as abdominal pain, dark urine, and weakness.
Stade de France Pharmacy